TickerFactsScreenerDevelopers

Larimar Therapeutics, Inc. (LRMR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$51.98M2017: -$43.78M2018: -$51.49M2019: -$22.70M2020: -$42.20M2021: -$42.10M2022: -$27.57M2023: -$33.46M2024: -$70.76M2025: -$113.20M-$113.20M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$113.20M-60.0%
2024-$70.76M-111.5%
2023-$33.46M-21.4%
2022-$27.57M+34.5%
2021-$42.10M+0.2%
2020-$42.20M-85.9%
2019-$22.70M+55.9%
2018-$51.49M-17.6%
2017-$43.78M+15.8%
2016-$51.98M—